CAPR- Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (CAPR) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. CAPR is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 116.1K | $3.07M | -900 | |
| Other | 80.0K | $2.12M | - | |
| Dir | 50.0K | $1.32M | - | |
| CEO | 50.0K | $1.32M | - | |
| VP | 30.5K | $807.7K | -900 |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | Avat Xavier48 | Chief Business Officer | Buy | 2,500 | $3.73 | $9,322.85 | +100.0% | +72.9% | +21.6% | |
| Jun 29, 2022 | Musket David B60 | Director | Sale+OE | 28,215 | $3.77 | $106,370.55 | -68.9% | +54.0% | +27.7% | |
| Jun 27, 2022 | Musket David B60 | Director | Sell | 17,775 | $4.44 | $78,921.00 | -30.3% | +30.6% | +12.0% | |
| May 9, 2017 | Manzo Louis | Director | Buy | 10,000 | $3.10 | $31,000.00 | +7.8% | - | - | |
| May 9, 2017 | Musket David B60 | Director | Buy | 25,000 | $3.10 | $77,500.00 | New | - | - | |
| May 9, 2017 | Cedars Sinai Medical Center | 10% Owner | Buy | 1,145,161 | $3.10 | $3,549,999.10 | +39.4% | - | - | |
| Sep 21, 2016 | Cedars Sinai Medical Center | 10% Owner | Buy | 312,500 | $3.20 | $1,000,000.00 | +12.1% | - | - | |
| Mar 16, 2016 | St. John Edward A. | 10% Owner | Buy | 833,332 | $2.40 | $1,999,996.80 | +97.9% | - | - | |
| Mar 16, 2016 | Gershell Leland | Chief Financial Officer | Buy | 2,100 | $2.40 | $5,040.00 | New | - | - | |
| Mar 16, 2016 | Krasney Karen | EVP, General Counsel | Buy | 4,060 | $2.40 | $9,744.00 | +57.2% | - | - |